Advance system testing: Vaccine benefit studies using multi-country electronic health data: the example of pertussis vaccination
The Accelerated Development of VAccine benefit-risk Collaboration in Europe (ADVANCE), a public-private consortium, implemented and tested a distributed network system for the generation of evidence on the benefits-risks of marketed vaccines in Europe. We tested the system by estimating the incidenc...
Main Authors: | Tin Tin Htar, M, De Ridder, M, Braeye, T, Correa, A, McGee, C, De Lusignan, S, Duarte-Salles, T, Huerta-Alvares, C, Martín-Merino, E, Tramontan, L, Danieli, G, Picelli, G, Van Der Maas, N, Berencsi, K, Arnheim-Dahlström, L, Heininger, U, Emborg, H, Weibel, D, Bollaerts, K, Sturkenboom, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2019
|
Similar Items
-
ADVANCE system testing: Can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: An example
by: Emborg, H, et al.
Published: (2019) -
ADVANCE system testing: estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data
by: Dodd, C, et al.
Published: (2020) -
ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinations
by: Sturkenboom, M, et al.
Published: (2020) -
Opportunities and challenges for near real time monitoring (NRTM) of vaccine exposures and outcomes in the participating databases of the ADVANCE consortium
by: Titievsky, L, et al.
Published: (2019) -
Pertussis vaccination in mixed markets: Recommendations from the Global Pertussis Initiative
by: Amar J. Chitkara, et al.
Published: (2020-07-01)